{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:20:20Z","timestamp":1795015220430,"version":"4.10.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2018YFA0107500"],"award-info":[{"award-number":["2018YFA0107500"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2021YFA1100600"],"award-info":[{"award-number":["2021YFA1100600"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930085"],"award-info":[{"award-number":["81930085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802864"],"award-info":[{"award-number":["81802864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32150710523"],"award-info":[{"award-number":["32150710523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mesenchymal stem\/stromal cells (MSCs) acquire immunosuppressive capacity only in an inflammatory microenvironment. This can be recapitulated in vitro by treating MSCs with inflammatory cytokines TNF\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IFN\n                      <jats:italic>\u03b3<\/jats:italic>\n                      , which induce indoleamine 2,3-dioxygenase (IDO) and TNF-stimulated gene-6 (TSG-6). However, the signaling pathways downstream of the cytokines remain to be elucidated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Inflammatory bowel disease (IBD) mouse model was established by subjecting mice to dextran sulfate sodium (DSS) in drinking water for 7\u00a0days. Human UC-MSCs were pretreated with TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      for 24\u00a0h and were then infused intravenously at day 2 of DSS administration. Colon tissues were collected for length measurement and histopathological examination. The serum level of IL-6 in mice was measured by enzyme-linked immunosorbent assay. Real-time PCR and Western blot were used to examine the mRNA level and protein expression. MSCs overexpressing constitutive active AKT or dominant negative AKT were generated and were analyzed. The glycolysis level of the MSCs was measured using Extracellular Flux Analyzer. 2-NBDG was used to monitor the uptake of glucose by MSCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TNF\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IFN\n                      <jats:italic>\u03b3<\/jats:italic>\n                      treatment led to rapid consumption of glucose and metabolic skewing toward glycolysis in MSCs, which was required for the therapeutic efficacy of MSCs on IBD. Blockade of glycolysis in MSCs inhibited the expression of immunomodulatory molecules, IDO and TSG-6, as well as the therapeutic effect on IBD. Moreover, PI3K-AKT signaling axis was rapidly activated and was required for the skewing toward glycolysis induced by TNF\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IFN\n                      <jats:italic>\u03b3<\/jats:italic>\n                      . MSCs expressing dominant negative AKT were compromised in their therapeutic efficacy on IBD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The glycolysis-dependent anti-inflammatory property of MSCs conferred by inflammatory cytokines is mediated by PI3K-AKT signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-022-03178-3","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T03:03:03Z","timestamp":1664852583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["TNF\u03b1 and IFN\u03b3 rapidly activate PI3K-AKT signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property"],"prefix":"10.1186","volume":"13","author":[{"given":"Chenchang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-9342","authenticated-orcid":false,"given":"Changshun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"issue":"9419","key":"3178_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439\u201341.","journal-title":"Lancet"},{"issue":"11","key":"3178_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009\u201316.","journal-title":"Nat Immunol"},{"issue":"1","key":"3178_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2016.193","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Du L, Lin L, Wang Y. Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2017;16(1):35\u201352.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"3178_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0002-9440(10)63018-0","volume":"159","author":"T Bardos","year":"2001","unstructured":"Bardos T, Kamath RV, Mikecz K, Glant TT. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis. Am J Pathol. 2001;159(5):1711\u201321.","journal-title":"Am J Pathol"},{"issue":"1","key":"3178_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"39","key":"3178_CR6","doi-asserted-by":"publisher","first-page":"16875","DOI":"10.1073\/pnas.1012451107","volume":"107","author":"JY Oh","year":"2010","unstructured":"Oh JY, Roddy GW, Choi H, Lee RH, Ylostalo JH, Rosa RH Jr, Prockop DJ. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A. 2010;107(39):16875\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3178_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","volume":"25","author":"G Wang","year":"2018","unstructured":"Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, Han Y, Rabson AB, Wang Y, Shi Y. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209\u201323.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3178_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-kappaB signaling in resident macrophages. Blood. 2011;118(2):330\u20138.","journal-title":"Blood"},{"issue":"7","key":"3178_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41375-018-0376-6","volume":"33","author":"R Jitschin","year":"2019","unstructured":"Jitschin R, Bottcher M, Saul D, Lukassen S, Bruns H, Loschinski R, Ekici AB, Reis A, Mackensen A, Mougiakakos D. Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation. Leukemia. 2019;33(7):1783\u201396.","journal-title":"Leukemia"},{"issue":"6","key":"3178_CR10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","volume":"29","author":"L Du","year":"2019","unstructured":"Du L, Lin L, Li Q, Liu K, Huang Y, Wang X, Cao K, Chen X, Cao W, Li F, et al. IGF-2 preprograms maturing macrophages to acquire oxidative phosphorylation-dependent anti-inflammatory properties. Cell Metab. 2019;29(6):1363-1375 e1368.","journal-title":"Cell Metab"},{"issue":"1","key":"3178_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4049\/jimmunol.1302164","volume":"192","author":"C Xu","year":"2014","unstructured":"Xu C, Yu P, Han X, Du L, Gan J, Wang Y, Shi Y. TGF-beta promotes immune responses in the presence of mesenchymal stem cells. J Immunol. 2014;192(1):103\u20139.","journal-title":"J Immunol"},{"issue":"8","key":"3178_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, Wang Y. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"issue":"31","key":"3178_CR13","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, Ylostalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107(31):13724\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141\u201350.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3178_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri2036","volume":"7","author":"C Rommel","year":"2007","unstructured":"Rommel C, Camps M, Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol. 2007;7(3):191\u2013201.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"3178_CR16","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","volume":"115","author":"DR Soond","year":"2010","unstructured":"Soond DR, Bjorgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM, Galleway F, Twomey B, Clark J, Gaston JS, et al. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood. 2010;115(11):2203\u201313.","journal-title":"Blood"},{"issue":"6","key":"3178_CR17","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/stem.1986","volume":"33","author":"M Mounayar","year":"2015","unstructured":"Mounayar M, Kefaloyianni E, Smith B, Solhjou Z, Maarouf OH, Azzi J, Chabtini L, Fiorina P, Kraus M, Briddell R, et al. PI3kalpha and STAT1 interplay regulates human mesenchymal stem cell immune polarization. Stem Cells. 2015;33(6):1892\u2013901.","journal-title":"Stem Cells"},{"issue":"23","key":"3178_CR18","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742\u20139.","journal-title":"Blood"},{"issue":"7","key":"3178_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006783","volume":"4","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Signaling in control of cell growth and metabolism. Cold Spring Harb Perspect Biol. 2012;4(7): a006783.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"3178_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):126.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3178_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, Au J, Long CP, Antoniewicz MR, Hay N. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018;9(1):446.","journal-title":"Nat Commun"},{"issue":"1","key":"3178_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2008.11.006","volume":"19","author":"SP Mathupala","year":"2009","unstructured":"Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer\u2019s stygian link to the \u201cWarburg Effect\u201d and a pivotal target for effective therapy. Semin Cancer Biol. 2009;19(1):17\u201324.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3178_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/sj.cdd.4402285","volume":"15","author":"S Miyamoto","year":"2008","unstructured":"Miyamoto S, Murphy AN, Brown JH. AKT mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008;15(3):521\u20139.","journal-title":"Cell Death Differ"},{"issue":"8","key":"3178_CR24","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.4049\/jimmunol.172.8.4661","volume":"172","author":"KA Frauwirth","year":"2004","unstructured":"Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol. 2004;172(8):4661\u20135.","journal-title":"J Immunol"},{"issue":"4","key":"3178_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(01)00205-9","volume":"15","author":"S Krauss","year":"2001","unstructured":"Krauss S, Brand MD, Buttgereit F. Signaling takes a breath\u2013new quantitative perspectives on bioenergetics and signal transduction. Immunity. 2001;15(4):497\u2013502.","journal-title":"Immunity"},{"issue":"6","key":"3178_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ni0602-515","volume":"3","author":"DR Plas","year":"2002","unstructured":"Plas DR, Rathmell JC, Thompson CB. Homeostatic control of lymphocyte survival: potential origins and implications. Nat Immunol. 2002;3(6):515\u201321.","journal-title":"Nat Immunol"},{"issue":"2","key":"3178_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.immuni.2007.07.008","volume":"27","author":"RG Jones","year":"2007","unstructured":"Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity. 2007;27(2):173\u20138.","journal-title":"Immunity"},{"issue":"6","key":"3178_CR28","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG, Rathmell JC. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299\u2013303.","journal-title":"J Immunol"},{"issue":"1","key":"3178_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","volume":"249","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt GJ, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev. 2012;249(1):27\u201342.","journal-title":"Immunol Rev"},{"key":"3178_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol. 2013;31:259\u201383.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"3178_CR31","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","volume":"193","author":"RP Donnelly","year":"2014","unstructured":"Donnelly RP, Loftus RM, Keating SE, Liou KT, Biron CA, Gardiner CM, Finlay DK. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J Immunol. 2014;193(9):4477\u201384.","journal-title":"J Immunol"},{"issue":"1","key":"3178_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O, Winter PS, Liu X, Priyadharshini B, Slawinska ME, et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest. 2015;125(1):194\u2013207.","journal-title":"J Clin Invest"},{"issue":"7","key":"3178_CR33","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.4049\/jimmunol.1600242","volume":"197","author":"M Galgani","year":"2016","unstructured":"Galgani M, De Rosa V, La Cava A, Matarese G. Role of metabolism in the immunobiology of regulatory T cells. J Immunol. 2016;197(7):2567\u201375.","journal-title":"J Immunol"},{"issue":"7","key":"3178_CR34","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208(7):1367\u201376.","journal-title":"J Exp Med"},{"issue":"3","key":"3178_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20150900","volume":"213","author":"T Shirai","year":"2016","unstructured":"Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, Tian L, Harrison DG, Giacomini JC, Assimes TL, et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med. 2016;213(3):337\u201354.","journal-title":"J Exp Med"},{"issue":"1","key":"3178_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4049\/jimmunol.0901698","volume":"185","author":"JC Rodriguez-Prados","year":"2010","unstructured":"Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, Cascante M, Bosca L. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010;185(1):605\u201314.","journal-title":"J Immunol"},{"issue":"6204","key":"3178_CR37","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345(6204):1250684.","journal-title":"Science"},{"issue":"4","key":"3178_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cmet.2011.11.013","volume":"15","author":"SK Biswas","year":"2012","unstructured":"Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab. 2012;15(4):432\u20137.","journal-title":"Cell Metab"},{"key":"3178_CR39","doi-asserted-by":"publisher","first-page":"9029327","DOI":"10.1155\/2017\/9029327","volume":"2017","author":"T Wang","year":"2017","unstructured":"Wang T, Liu H, Lian G, Zhang SY, Wang X, Jiang C. HIF1alpha-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediat Inflamm. 2017;2017:9029327.","journal-title":"Mediat Inflamm"},{"issue":"3","key":"3178_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2018.08.012","volume":"28","author":"F Wang","year":"2018","unstructured":"Wang F, Zhang S, Vuckovic I, Jeon R, Lerman A, Folmes CD, Dzeja PP, Herrmann J. Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab. 2018;28(3):463-475 e464.","journal-title":"Cell Metab"},{"key":"3178_CR41","first-page":"420","volume":"5","author":"S Galvan-Pena","year":"2014","unstructured":"Galvan-Pena S, O\u2019Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol. 2014;5:420.","journal-title":"Front Immunol"},{"issue":"1","key":"3178_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman NM, Boothby MR, Chi H. Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2020;20(1):55\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3178_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O'Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3178_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3892\/ijo.2016.3804","volume":"50","author":"Y Wang","year":"2017","unstructured":"Wang Y, Kuramitsu Y, Baron B, Kitagawa T, Tokuda K, Akada J, Maehara SI, Maehara Y, Nakamura K. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells. Int J Oncol. 2017;50(2):606\u201312.","journal-title":"Int J Oncol"},{"issue":"4","key":"3178_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487\u2013501.","journal-title":"Cell"},{"issue":"1","key":"3178_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","volume":"10","author":"H Wajant","year":"2003","unstructured":"Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45\u201365.","journal-title":"Cell Death Differ"},{"issue":"43","key":"3178_CR47","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.1074\/jbc.M505291200","volume":"280","author":"AL Theiss","year":"2005","unstructured":"Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem. 2005;280(43):36099\u2013109.","journal-title":"J Biol Chem"},{"issue":"2","key":"3178_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1471-4906(01)02118-4","volume":"23","author":"CV Ramana","year":"2002","unstructured":"Ramana CV, Gil MP, Schreiber RD, Stark GR. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 2002;23(2):96\u2013101.","journal-title":"Trends Immunol"},{"issue":"36","key":"3178_CR49","doi-asserted-by":"publisher","first-page":"33361","DOI":"10.1074\/jbc.M105070200","volume":"276","author":"H Nguyen","year":"2001","unstructured":"Nguyen H, Ramana CV, Bayes J, Stark GR. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem. 2001;276(36):33361\u20138.","journal-title":"J Biol Chem"},{"issue":"5930","key":"3178_CR50","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"12","key":"3178_CR51","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nm.1890","volume":"14","author":"JA Engelman","year":"2008","unstructured":"Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, Maira M, McNamara K, Perera SA, Song Y, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med. 2008;14(12):1351\u20136.","journal-title":"Nat Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03178-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03178-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03178-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T04:09:03Z","timestamp":1664856543000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03178-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03178-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The methods of animal sacrifice, tissue management and disposal of dead animal bodies were reviewed and approved by the Ethics Committee of Soochow University (SUDA20210916A07).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"491"}}